Hi ,

We all know how hard it is to bring a novel therapeutic to market, from scientific and manufacturing challenges through the regulatory obstacle course. That's why SynBioBeta, and Mintz are hosting a Regulatory Insights and Manufacturing Strategies Breakfast on Sept. 20th during Biotech Week Boston. Network with fellow leaders and hear from industry experts, including Jeffrey Baker, former Deputy Director of Biotechnology Products at the FDA, on what it takes to bring a therapy to market. 

Are you a biotech leader who should be in this room? Reach out to us to join!

Christina Smolke, PhD, CEO and co-founder of Antheia.

The deadline on our call for speakers for SynBioBeta 2024: The Global Synthetic Biology Conference is September 8th and is quickly approaching. We want to hear from you! We aim to bring even more diverse voices to the forefront of the conversation around synthetic biology, and we are looking for speakers to share their expertise, spark thoughtful discussions, and lead education sessions for various aspects of SynBio. It will be our biggest event yet—we expect over 3,000 attendees! We can’t wait to see you there.

Other news:



John Cumbers

CEO, SynBioBeta

Who's hiring?

Email Marketing by ActiveCampaign